@article{Naidoo2024,
abstract = {Drug-resistant tuberculosis (DR-TB) threatens to derail tuberculosis control efforts, particularly in Africa where the disease remains out of control. The dogma that DR-TB epidemics are fueled by unchecked rates of acquired resistance in inadequately treated or non-adherent individuals is no longer valid in most high DR-TB burden settings, where community transmission is now widespread. A large burden of DR-TB in Africa remains undiagnosed due to inadequate access to diagnostic tools that simultaneously detect tuberculosis and screen for resistance. Furthermore, acquisition of drug resistance to new and repurposed drugs, for which diagnostic solutions are not yet available, presents a major challenge for the implementation of novel, all-oral, shortened (6–9 months) treatment. Structural challenges including poverty, stigma, and social distress disrupt engagement in care, promote poor treatment outcomes, and reduce the quality of life for people with DR-TB. We reflect on the lessons learnt from the South African experience in implementing state-of-the-art advances in diagnostic solutions, deploying recent innovations in pharmacotherapeutic approaches for rapid cure, understanding local transmission dynamics and implementing interventions to curtail DR-TB transmission, and in mitigating the catastrophic socioeconomic costs of DR-TB. We also highlight globally relevant and locally responsive research priorities for achieving DR-TB control in South Africa. {\textcopyright} 2024 Elsevier Ltd},
author = {Naidoo, Kogieleum and Perumal, Rubeshan and Cox, Helen and Mathema, Barun and Loveday, Marian and Ismail, Nazir and Omar, Shaheed Vally and Georghiou, Sophia B and Daftary, Amrita and O'Donnell, Max and Ndjeka, Norbert},
doi = {10.1016/S1473-3099(24)00144-0},
file = {:C$\backslash$:/Users/01462563/AppData/Local/Mendeley Ltd./Mendeley Desktop/Downloaded/Naidoo et al. - 2024 - The epidemiology, transmission, diagnosis, and management of drug-resistant tuberculosis—lessons from the South A.pdf:pdf},
issn = {14744457},
journal = {The Lancet Infectious Diseases},
keywords = {fund{\_}not{\_}ack,review},
mendeley-tags = {fund{\_}not{\_}ack,review},
pages = {10.1016/S1473--3099(24)00144--0},
publisher = {Elsevier Ltd},
title = {{The epidemiology, transmission, diagnosis, and management of drug-resistant tuberculosis—lessons from the South African experience}},
year = {2024}
}

{"_id":"bZvpjfEELMptFRP2i","bibbaseid":"naidoo-perumal-cox-mathema-loveday-ismail-omar-georghiou-etal-theepidemiologytransmissiondiagnosisandmanagementofdrugresistanttuberculosislessonsfromthesouthafricanexperience-2024","author_short":["Naidoo, K.","Perumal, R.","Cox, H.","Mathema, B.","Loveday, M.","Ismail, N.","Omar, S. V.","Georghiou, S. B","Daftary, A.","O'Donnell, M.","Ndjeka, N."],"bibdata":{"bibtype":"article","type":"article","abstract":"Drug-resistant tuberculosis (DR-TB) threatens to derail tuberculosis control efforts, particularly in Africa where the disease remains out of control. The dogma that DR-TB epidemics are fueled by unchecked rates of acquired resistance in inadequately treated or non-adherent individuals is no longer valid in most high DR-TB burden settings, where community transmission is now widespread. A large burden of DR-TB in Africa remains undiagnosed due to inadequate access to diagnostic tools that simultaneously detect tuberculosis and screen for resistance. Furthermore, acquisition of drug resistance to new and repurposed drugs, for which diagnostic solutions are not yet available, presents a major challenge for the implementation of novel, all-oral, shortened (6–9 months) treatment. Structural challenges including poverty, stigma, and social distress disrupt engagement in care, promote poor treatment outcomes, and reduce the quality of life for people with DR-TB. We reflect on the lessons learnt from the South African experience in implementing state-of-the-art advances in diagnostic solutions, deploying recent innovations in pharmacotherapeutic approaches for rapid cure, understanding local transmission dynamics and implementing interventions to curtail DR-TB transmission, and in mitigating the catastrophic socioeconomic costs of DR-TB. We also highlight globally relevant and locally responsive research priorities for achieving DR-TB control in South Africa. © 2024 Elsevier Ltd","author":[{"propositions":[],"lastnames":["Naidoo"],"firstnames":["Kogieleum"],"suffixes":[]},{"propositions":[],"lastnames":["Perumal"],"firstnames":["Rubeshan"],"suffixes":[]},{"propositions":[],"lastnames":["Cox"],"firstnames":["Helen"],"suffixes":[]},{"propositions":[],"lastnames":["Mathema"],"firstnames":["Barun"],"suffixes":[]},{"propositions":[],"lastnames":["Loveday"],"firstnames":["Marian"],"suffixes":[]},{"propositions":[],"lastnames":["Ismail"],"firstnames":["Nazir"],"suffixes":[]},{"propositions":[],"lastnames":["Omar"],"firstnames":["Shaheed","Vally"],"suffixes":[]},{"propositions":[],"lastnames":["Georghiou"],"firstnames":["Sophia","B"],"suffixes":[]},{"propositions":[],"lastnames":["Daftary"],"firstnames":["Amrita"],"suffixes":[]},{"propositions":[],"lastnames":["O'Donnell"],"firstnames":["Max"],"suffixes":[]},{"propositions":[],"lastnames":["Ndjeka"],"firstnames":["Norbert"],"suffixes":[]}],"doi":"10.1016/S1473-3099(24)00144-0","file":":C$\\$:/Users/01462563/AppData/Local/Mendeley Ltd./Mendeley Desktop/Downloaded/Naidoo et al. - 2024 - The epidemiology, transmission, diagnosis, and management of drug-resistant tuberculosis—lessons from the South A.pdf:pdf","issn":"14744457","journal":"The Lancet Infectious Diseases","keywords":"fund_not_ack,review","mendeley-tags":"fund_not_ack,review","pages":"10.1016/S1473–3099(24)00144–0","publisher":"Elsevier Ltd","title":"The epidemiology, transmission, diagnosis, and management of drug-resistant tuberculosis—lessons from the South African experience","year":"2024","bibtex":"@article{Naidoo2024,\r\nabstract = {Drug-resistant tuberculosis (DR-TB) threatens to derail tuberculosis control efforts, particularly in Africa where the disease remains out of control. The dogma that DR-TB epidemics are fueled by unchecked rates of acquired resistance in inadequately treated or non-adherent individuals is no longer valid in most high DR-TB burden settings, where community transmission is now widespread. A large burden of DR-TB in Africa remains undiagnosed due to inadequate access to diagnostic tools that simultaneously detect tuberculosis and screen for resistance. Furthermore, acquisition of drug resistance to new and repurposed drugs, for which diagnostic solutions are not yet available, presents a major challenge for the implementation of novel, all-oral, shortened (6–9 months) treatment. Structural challenges including poverty, stigma, and social distress disrupt engagement in care, promote poor treatment outcomes, and reduce the quality of life for people with DR-TB. We reflect on the lessons learnt from the South African experience in implementing state-of-the-art advances in diagnostic solutions, deploying recent innovations in pharmacotherapeutic approaches for rapid cure, understanding local transmission dynamics and implementing interventions to curtail DR-TB transmission, and in mitigating the catastrophic socioeconomic costs of DR-TB. We also highlight globally relevant and locally responsive research priorities for achieving DR-TB control in South Africa. {\\textcopyright} 2024 Elsevier Ltd},\r\nauthor = {Naidoo, Kogieleum and Perumal, Rubeshan and Cox, Helen and Mathema, Barun and Loveday, Marian and Ismail, Nazir and Omar, Shaheed Vally and Georghiou, Sophia B and Daftary, Amrita and O'Donnell, Max and Ndjeka, Norbert},\r\ndoi = {10.1016/S1473-3099(24)00144-0},\r\nfile = {:C$\\backslash$:/Users/01462563/AppData/Local/Mendeley Ltd./Mendeley Desktop/Downloaded/Naidoo et al. - 2024 - The epidemiology, transmission, diagnosis, and management of drug-resistant tuberculosis—lessons from the South A.pdf:pdf},\r\nissn = {14744457},\r\njournal = {The Lancet Infectious Diseases},\r\nkeywords = {fund{\\_}not{\\_}ack,review},\r\nmendeley-tags = {fund{\\_}not{\\_}ack,review},\r\npages = {10.1016/S1473--3099(24)00144--0},\r\npublisher = {Elsevier Ltd},\r\ntitle = {{The epidemiology, transmission, diagnosis, and management of drug-resistant tuberculosis—lessons from the South African experience}},\r\nyear = {2024}\r\n}\r\n","author_short":["Naidoo, K.","Perumal, R.","Cox, H.","Mathema, B.","Loveday, M.","Ismail, N.","Omar, S. V.","Georghiou, S. B","Daftary, A.","O'Donnell, M.","Ndjeka, N."],"key":"Naidoo2024","id":"Naidoo2024","bibbaseid":"naidoo-perumal-cox-mathema-loveday-ismail-omar-georghiou-etal-theepidemiologytransmissiondiagnosisandmanagementofdrugresistanttuberculosislessonsfromthesouthafricanexperience-2024","role":"author","urls":{},"keyword":["fund_not_ack","review"],"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://drive.google.com/uc?export=download&id=1-JLqZ7RwZ3VC2d6ErLGHAtOeMRS_7GCz","dataSources":["Krmt6gt9ktB2s6ARh"],"keywords":["fund_not_ack","review"],"search_terms":["epidemiology","transmission","diagnosis","management","drug","resistant","tuberculosis","lessons","south","african","experience","naidoo","perumal","cox","mathema","loveday","ismail","omar","georghiou","daftary","o'donnell","ndjeka"],"title":"The epidemiology, transmission, diagnosis, and management of drug-resistant tuberculosis—lessons from the South African experience","year":2024}